Testosterone Cypionate Self-Injection: Route, Supplies and Lab Timing

Have your clinician demonstrate the route, site and equipment before your first prescribed self-injection. Check the medicine, prescribed dose, concentration, measured volume and taught injection site each time. General intramuscular injection guidance also emphasizes handwashing, clean equipment and knowing the correct site before proceeding. 1

Make a product-and-prescription check record

Keep this record beside your supplies and update it whenever the prescription or dispensed product changes:

This record brings together checks that otherwise sit in different places: the prescription, vial label and injection teaching. Depo-Testosterone comes in 100 mg/mL and 200 mg/mL strengths; its label specifies IM use. Vial handling also depends on whether the actual container is single-dose or multidose. 2 3

Milligrams and milliliters are different

Milligrams describe the amount of medicine; milliliters describe the liquid volume. Calculate volume as prescribed milligrams divided by concentration in mg/mL.

For a hypothetical prescription of 50 mg:

• At 100 mg/mL: 50 ÷ 100 = 0.5 mL.
• At 200 mg/mL: 50 ÷ 200 = 0.25 mL.

These examples explain concentration arithmetic; they are not dose recommendations. Both concentrations are available for Depo-Testosterone. If your prescription, label and expected syringe volume disagree, have the pharmacist or prescriber reconcile them before injecting. 2 1

Confirm the route before choosing equipment

Depo-Testosterone’s US label specifies deep gluteal IM administration and says it is not for intravenous use. Clinicians also prescribe testosterone cypionate subcutaneously, an off-label route described in UCSF’s masculinizing-therapy guidance. SC cypionate requires its own prescribed plan. Do not switch routes or substitute sites on your own. 2 4

The often-cited weekly SC cypionate study followed 11 transgender male adults already receiving that treatment. Researchers measured testosterone at eight points over one week and found relatively stable average concentrations. It was a small descriptive study, not a randomized IM-versus-SC comparison across all patient populations. It does not establish that the routes have identical safety or outcomes for everyone. 5

Ask your trainer to specify syringe capacity and markings, needle length and gauge, whether separate drawing and injection needles are intended, and the exact site and technique for your plan. For IM injections, the needle must reach muscle; a universal needle recommendation cannot account for every body and site. 1

Prepare a clean workspace and the right supplies

Gather the correct vial, prescribed syringe and needles, alcohol wipes, clean gauze and a sharps container before starting. Wash your hands and check the medicine and amount against the prescription. Use only the site-identification and injection technique you were taught. 1

For vial access, disinfect the rubber stopper with alcohol and let it dry. Use a new sterile needle and syringe; do not leave a needle in the stopper between uses. Clean the injection skin with an alcohol wipe and let it dry before injecting. If equipment becomes contaminated or vial sterility is uncertain, replace it rather than proceeding. 3 1

Have your clinician demonstrate any steps you cannot confidently repeat, including whether your particular technique includes aspiration. General instructions are not a reason to improvise an angle, injection speed or maximum volume for your prescribed route. 1

Handle single-dose and multidose vials differently

Read the designation on the actual vial; do not infer it from container size. A single-dose vial is not a supply to save for later injections, even when the remaining medicine would be used by the same person. Discard the remainder after use. 3

For a punctured multidose vial, CDC guidance generally calls for disposal within 28 days unless the manufacturer specifies a different opened-vial period. Never extend use beyond the original expiration date. Mark the first-puncture and discard dates so you do not have to reconstruct them later. 3

Depo-Testosterone storage instructions specify room temperature, 20–25°C, protected from light. Follow the instructions for the product actually dispensed rather than adding refrigeration or an improvised warming routine. 6

Finish safely and recognize problems

After withdrawing the needle, apply gentle pressure with clean gauze if needed. Put used needles and syringes directly into an appropriate sharps container. FDA guidance favors a purpose-made container; when unavailable, an appropriate heavy-duty household container may be an alternative. Follow local disposal requirements and replace the container at its fill line or about three-quarters full. 1 7

Record the injection date, time, amount, route and site. Include any unusual reaction so your clinician can review it alongside symptoms and laboratory results. Injection-site pain and inflammation are recognized adverse reactions to testosterone cypionate. Increasing redness, swelling, persistent bleeding or pain that does not settle warrants clinical advice. 2 1

Sudden breathing difficulty, chest pain, fainting or swelling of the face or throat requires emergency care. AVEED’s boxed warning for pulmonary oil microembolism (POME) and anaphylaxis concerns testosterone undecanoate, not testosterone cypionate. Its mandatory 30-minute observation period should not be transferred to home cypionate injections, but that distinction does not make alarming symptoms safe to watch at home. 2 8

Plan blood draws around the prescription

For injectable testosterone cypionate or enanthate used for male hypogonadism, the 2018 Endocrine Society guideline recommends measuring testosterone midway between injections. Its mid-interval thresholds of below 350 or above 600 ng/dL guide clinician review of dose or frequency; they are not a self-adjustment formula. 9

Your prescriber chooses the actual draw timing for your indication, schedule and symptoms. Some circumstances call for peak or trough assessment. Bring the date and time of your last injection, its dose, and the blood-draw time so the result can be interpreted correctly. 4

The 2018 guideline recommends hematocrit before treatment, at three to six months and annually thereafter. A hematocrit above 54% requires clinician-directed interruption and evaluation before an adjusted restart. Blood pressure also needs monitoring. Prostate testing depends on age, risk, relevant anatomy and shared decisions—not a universal PSA requirement for every testosterone user. 9 2